title: Phase II evaluation of thioTEPA for treatment of central nervous system tumors.
abstract: Nineteen patients with primary malignant gliomas were treated with thioTEPA. It was found to be ineffective in 13 evaluable patients.
mesh_terms: D000293:Adolescent; D000328:Adult; D001254:Astrocytoma / Q000188:drug therapy; D001932:Brain Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005909:Glioblastoma / Q000188:drug therapy; D005910:Glioma / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D013852:Thiotepa / Q000627:therapeutic use*
chemical_list: D013852:Thiotepa